International Business News - Bristol http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Vincent "Buddy" Cianci may not be mayor of Providence anymore, but he's resuming one of the public duties he lost when he was sent to prison in 2002 for corruption. http://www.ibtimes.com/articles/20080703/former-mayor-to-march-in-r-i-july-4th-parade.htm Thu, 03 Jul 2008 10:06:03 EDT Bristol-Myers Squibb completed its $234.6 million acquisition of Kosan Biosciences, the company said late Thursday. Excluding Kosan's cash balance, Bristol is paying about $190 million in cash for the company. Bristol previously said it is financing the deal with cash on hand. http://www.ibtimes.com/articles/20080627/bristol-myers-squibb-completes-kosan-acquisition.htm Fri, 27 Jun 2008 09:14:12 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Wednesday the Hart-Scott-Rodino review period for its tender offer for cancer therapy maker Kosan Biosciences Inc. has expired. http://www.ibtimes.com/articles/20080618/bristol-myers-review-period-ends-for-kosan-deal.htm Wed, 18 Jun 2008 08:42:17 EDT Biopharmaceutical company Bristol-Myers Squibb Co. spent $840,000 lobbying on drug and patent issues in the first quarter, according to a recent disclosure form. http://www.ibtimes.com/articles/20080613/bristol-myers-spent-840-000-on-lobbying-in-1q.htm Fri, 13 Jun 2008 14:48:49 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Thursday that according to a study, patients given its drug Orencia to treat a type of arthritic pain over three years did not see a worsening of the disease. http://www.ibtimes.com/articles/20080612/bristol-myers-says-drug-blocks-spread-of-arthritis.htm Thu, 12 Jun 2008 09:05:52 EDT Shares of Bristol-Myers Squibb Co. sank to their lowest level in almost six years Tuesday as analysts expressed concerns with side effects associated with the two of the company's experimental diabetes drugs. http://www.ibtimes.com/articles/20080610/bristol-shares-hit-6-year-low-on-diabetes-data.htm Tue, 10 Jun 2008 17:08:14 EDT IBM Corp. said Thursday it will provide human resources services to Bristol-Myers Squibb Co. under a 10-year, $324 million contract. The contract is part of the New York-based drugmaker's effort to control costs and streamline its organization. http://www.ibtimes.com/articles/20080605/ibm-gets-10-year-324-million-bristol-myers-pact.htm Thu, 05 Jun 2008 10:04:18 EDT Drug developer Bristol-Myers Squibb Co. reaffirmed its full-year profit guidance following the company's announcement it will by Kosan Biosciences for $5.50 per share in cash. http://www.ibtimes.com/articles/20080529/bristol-myers-reaffirms-2008-guidance.htm Thu, 29 May 2008 17:01:23 EDT Drug developer Bristol-Myers Squibb Co. said Thursday it will pay $5.50 per share in cash for cancer therapy maker Kosan Biosciences Inc., in a move to enhance its cancer treatment pipeline. http://www.ibtimes.com/articles/20080529/bristol-myers-to-buy-kosan-for-5-50-per-share.htm Thu, 29 May 2008 11:45:45 EDT Bristol-Myers Squibb Co. said Tuesday it signed a deal with KAI Pharmaceuticals to develop and sell KAI's mid-stage cardiovascular disease candidate KAI-9803. http://www.ibtimes.com/articles/20080513/bristol-myers-squibb-kai-in-development-agreement.htm Tue, 13 May 2008 10:34:34 EDT Bristol-Myers Squibb Co. and Japanese partner Otsuka Pharmaceutical Co. said Thursday federal regulators expanded approval for Abilify to aid with the treatment of bipolar disorder. http://www.ibtimes.com/articles/20080508/fda-oks-abilify-for-secondary-use-against-bipolar-disorder.htm Thu, 08 May 2008 18:27:01 EDT Bristol-Myers Squibb Co. will hold its annual stockholder meeting Tuesday and Wall Street may be looking for further updates on the company's ongoing restructuring plan. http://www.ibtimes.com/articles/20080506/ahead-of-the-bell-bristol-myers-squibb-holds-annual-meeting.htm Tue, 06 May 2008 06:24:12 EDT Bristol-Myers Squibb Co. said on Friday it will sell its ConvaTec unit to private equity firms Nordic Capital and Avista Capital Partners for $4.1 billion. http://www.ibtimes.com/articles/20080502/bristol-myers-squibb-convatec-sale.htm Fri, 02 May 2008 22:17:51 EDT Drug developer Bristol-Myers Squibb Co. says it plans to sell its wound therapy unit to Nordic Capital Fund VII for $4.1 billion. The ConvaTec unit makes wound therapy and surgical care products. The deal is part of an ongoing restructuring process at Bristol-Myers that has already resulted in the sale of its medical imaging unit and plans to file an IPO to sell between 10 percent and 20 percent of its Mead Johnson Nutritional unit. http://www.ibtimes.com/articles/20080502/bristol-myers-squibb-sells-unit-for-4-1-billion.htm Fri, 02 May 2008 16:41:37 EDT The drugmaker Bristol-Myers Squibb Co. said Thursday its first-quarter profit fell on higher restructuring costs and taxes, but adjusted results topped Wall Street forecasts. http://www.ibtimes.com/articles/20080424/bristol-myers-1q-profit-falls-on-restructuring-costs.htm Thu, 24 Apr 2008 11:55:23 EDT A former vice-president at the Pharmaceutical Bristol-Myers Squibb Co. was indicted as the U.S. Department of Justice said he lied to the federal government about a patent deal related to the blood-thinning drug Plavix. http://www.ibtimes.com/articles/20080424/bristol-myers-squibb-bodnar-plavix.htm Thu, 24 Apr 2008 02:29:31 EDT A former executive at Bristol-Myers Squibb was charged Wednesday with lying to federal authorities about a patent deal involving the blood-thinning drug Plavix. http://www.ibtimes.com/articles/20080423/ex-bristol-myers-squibb-exec-indicted-in-antitrust-probe.htm Wed, 23 Apr 2008 16:41:45 EDT Bristol-Myers Squibb Co. agreed today to pay $5 million plus royalties to Repligen Corp. to settle a patent infringement lawsuit for a rheumatoid arthritis treatment. http://www.ibtimes.com/articles/20080408/bristol-myers-repligen-orencia.htm Tue, 08 Apr 2008 18:22:06 EDT Isis Pharmaceuticals Inc. said Tuesday it will receive a $2 million milestone payment now that Bristol-Myers Squibb Co. has selected one of the company's compounds for development. The development ... http://www.ibtimes.com/articles/20080408/isis-gets-2m-payment-from-bristol-myers.htm Tue, 08 Apr 2008 08:17:38 EDT Bristol-Myers Squibb Co. Chief Executive James M. Cornelius received a sharp boost in executive compensation in 2007 as the company faced tougher generic competition prospects and a thinning development pipeline. http://www.ibtimes.com/articles/20080324/bristol-myers-ceo-compensation-surges.htm Mon, 24 Mar 2008 16:55:13 EDT